# Severe Bullous Drug Eruption and Filgrastim

> **NCT04651439** · PHASE2,PHASE3 · RECRUITING · sponsor: **Hospices Civils de Lyon** · enrollment: 42 (estimated)

## Conditions studied

- Rare Diseases
- Toxic Epidermal Necrolyses

## Interventions

- **DRUG:** Filgrastim
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04651439
- **Lead sponsor:** Hospices Civils de Lyon
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-05-13
- **Primary completion:** 2025-05-18
- **Final completion:** 2026-05-13
- **Target enrollment:** 42 (ESTIMATED)
- **Last updated:** 2024-05-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04651439

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04651439, "Severe Bullous Drug Eruption and Filgrastim". Retrieved via AI Analytics 2026-09-17 from https://api.ai-analytics.org/clinical/NCT04651439. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*